Evidence map›Paper›PMID 25457301›Full record

ReviewTravel medicine and infectious disease

Middle East respiratory syndrome coronavirus (MERS-CoV): prevention in travelers.

Androula Pavli, Sotirios Tsiodras, Helena C Maltezou

Abstract readReview
In one paragraph

Review in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The spectrum of respiratory pathogens among returning Hajj pilgrims: myths and reality.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2016
    Article
  17. Article
  18. Middle East Respiratory Syndrome--need for increased vigilance and watchful surveillance for MERS-CoV in sub-Saharan Africa.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2015
    Article
  19. No evidence of MERS-CoV in Ghanaian Hajj pilgrims: cautious interpretation is needed.Tropical medicine & international health : TM & IH · 2015
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Androula PavliTravel Medicine Office, Athens, Greece.
Sotirios TsiodrasHellenic Center for Disease Control and Prevention, Athens, Greece; University of Athens Medical School, Athens, Greece.
Helena C MaltezouDepartment for Interventions in Health Care Facilities, Athens, Greece. Electronic address: helen-maltezou@ath.forthnet.gr.
Hellenic Center for Disease Control & Prevention · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV), a novel coronavirus that causes a severe lower respiratory tract infection in humans, emerged in the Middle East in 2012. Since then, MERS-CoV has caused an ongoing epidemic in the Arabian Peninsula with sporadic cases imported in Europe, North Africa, Southeast Asia, and the United States of America. As of 28th May 2014, 636 laboratory-confirmed cases of infection with MERS-CoV have been reported to World Health Organization including 14 cases imported by travelers. The epicenter of the current MERS-CoV epidemic is located in Saudi Arabia, where millions of pilgrims travel for two mass gatherings annually. In this review we summarize MERS-CoV cases in relation to travel with focus on the epidemiology and prevention in travelers. It is important to increase awareness of travelers about the risks and appropriate preventive measures and for health professionals to be on alert if a patient with severe respiratory symptoms reports a recent history of travel to the region affected with MERS-CoV. Measures should be taken by local health authorities of the affected countries in order to improve hospital hygiene. Finally, it is crucial to investigate the reasons for travelers' poor compliance with rules and recommendations issued by Saudi officials and to take appropriate measures in order to improve them.

Indexed as

Coronavirus InfectionsMiddle East Respiratory Syndrome CoronavirusTravelAnimalsCamelusCommunicable Disease ControlDisease OutbreaksHumansRisk FactorsSaudi ArabiaZoonosesImported casesMERS-CoVPreventionTravelers

Identifiers

PMID25457301
PMCPMC7110598
OpenAlexW2122502625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.